Ignite Creation Date:
2025-12-24 @ 1:17 PM
Ignite Modification Date:
2025-12-28 @ 4:25 PM
Study NCT ID:
NCT06240195
Status:
RECRUITING
Last Update Posted:
2024-03-25
First Post:
2024-01-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Biomarkers of Efficacy and Tolerability of Sacituzumab-Govitecan in the Treatment of Patients With Triple-negative Breast Cancer in the Metastatic Phase: Prospective Multicenter Real-world Study
Sponsor:
Regina Elena Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-17
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-17
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06-17
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-12
First Submit QC Date:
None
Study First Post Date:
2024-02-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-21
Last Update Post Date:
2024-03-25
Last Update Post Date Type:
ACTUAL